THUNDEROBOT
872190
Ji Yao Holding Group
300108
Hangzhou Huasu Technology
301157
Flaircomm Microelectronics, Inc.
301600
Jiusheng Electric
301082
CN Stock MarketDetailed Quotes
603520 Zhejiang Starry Pharmaceutical
- 8.70
- -0.40-4.40%
Not Open Jan 7 15:00 CST
3.81BMarket Cap271.88P/E (TTM)
9.04High8.51Low165.89KlotVolume9.04Open9.10Pre Close145.27MTurnover3.78%Turnover Ratio86.14P/E (Static)438.41MShares13.5752wk High1.43P/B3.81BFloat Cap7.3252wk Low10.01Limit Up438.41MShs Float69.39Historical High8.19Limit Down5.82%Amplitude4.72Historical Low0.05Dividend TTM8.76Avg Price98.38KlotAsk0.57%Div YieldTTM100Lot Size62.63KlotBid
Zhejiang Starry Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -3.31%1.56B | -1.29%1.06B | -7.94%448.76M | 31.15%2.33B | 26.06%1.62B | 37.75%1.08B | 22.79%487.45M | 0.25%1.78B | 9.65%1.28B | 2.30%780.85M |
| Refunds of taxes and levies | -27.60%46.62M | -32.07%26.03M | -31.28%16M | 37.35%83.53M | 52.10%64.39M | 108.40%38.33M | 163.71%23.28M | 78.80%60.81M | 32.56%42.33M | -15.35%18.39M |
| Cash received relating to other operating activities | 64.17%131.1M | 126.29%118.16M | 88.26%73.25M | 42.84%785.71M | -69.94%79.86M | -72.57%52.22M | -63.23%38.91M | 12.21%550.06M | -15.46%265.64M | 8.30%190.37M |
| Cash inflows from operating activities | -1.14%1.74B | 3.41%1.21B | -2.12%538M | 34.00%3.2B | 10.72%1.76B | 17.84%1.17B | 7.43%549.64M | 3.96%2.39B | 4.93%1.59B | 2.99%989.61M |
| Goods services cash paid | -10.37%1.19B | -11.94%798.39M | -24.20%349.39M | 23.49%1.95B | 8.74%1.33B | 11.10%906.65M | 23.22%460.94M | 78.91%1.58B | 81.20%1.22B | 115.85%816.08M |
| Staff behalf paid | -2.38%184.76M | -0.41%124.98M | 4.59%67.71M | 3.19%257.4M | 4.44%189.26M | 2.47%125.5M | -9.13%64.74M | 15.60%249.45M | 18.27%181.22M | 21.49%122.47M |
| All taxes paid | -19.41%45.4M | -29.02%34.28M | -49.53%15.58M | -69.79%31.67M | -63.43%56.33M | -58.77%48.3M | -48.97%30.86M | -12.78%104.81M | 11.77%154.02M | 39.05%117.13M |
| Cash paid relating to other operating activities | 140.16%326.48M | 78.01%230.71M | -62.38%13.24M | 71.65%920.63M | -21.57%135.94M | 10.28%129.61M | -64.64%35.19M | -6.35%536.33M | -46.50%173.34M | -52.64%117.52M |
| Cash outflows from operating activities | 2.19%1.75B | -1.79%1.19B | -24.64%445.91M | 27.94%3.16B | -1.17%1.71B | 3.14%1.21B | -2.24%591.72M | 37.87%2.47B | 34.20%1.73B | 44.62%1.17B |
| Net cash flows from operating activities | -111.49%-5.92M | 140.04%17.58M | 318.83%92.09M | 156.85%44.55M | 136.97%51.52M | 76.09%-43.89M | 55.07%-42.08M | -115.40%-78.37M | -161.42%-139.37M | -222.74%-183.6M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | -79.25%19.8M | -87.46%10M | ---- | ---- | --95.41M | -2.64%79.74M | -2.64%79.74M |
| Cash received from returns on investments | ---- | ---- | ---- | 1,721.95%1.57M | -89.96%1.57M | -89.96%1.57M | --1.57M | -95.64%86.39K | --15.67M | --15.67M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | ---- | 1,022.29%18.88M | 1,993.37%6.15M | 1,993.37%6.15M | --6M | -76.78%1.68M | -94.00%293.9K | -90.68%293.9K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --30.93M | --30.94M | --30.94M |
| Cash received relating to other investing activities | ---- | ---- | ---- | -67.10%66.08M | ---- | ---- | ---- | -79.21%200.84M | -67.84%200.89M | -45.89%190.87M |
| Cash inflows from investing activities | ---- | ---- | ---- | -67.68%106.33M | -94.59%17.73M | -97.57%7.73M | -95.31%7.57M | -66.27%328.95M | -53.97%327.53M | -27.47%317.51M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 34.53%288.35M | -7.42%153.04M | 20.95%96.58M | -43.62%266.22M | -47.32%214.33M | -42.48%165.31M | -40.96%79.85M | 55.39%472.18M | 188.31%406.85M | 252.08%287.42M |
| Cash paid to acquire investments | -59.64%11.3M | -98.21%500K | ---- | -50.00%28M | -37.22%28M | -37.22%28M | ---- | 74.84%56M | 123.00%44.6M | 123.00%44.6M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | -50.30%66.1M | ---- | ---- | ---- | -85.22%132.99M | -80.30%130M | -70.45%130M |
| Cash outflows from investing activities | 23.65%299.65M | -20.57%153.54M | 20.95%96.58M | -45.50%360.32M | -58.32%242.33M | -58.16%193.31M | -65.41%79.85M | -47.43%661.17M | -31.27%581.45M | -14.70%462.02M |
| Net cash flows from investing activities | -33.41%-299.65M | 17.26%-153.54M | -33.63%-96.58M | 23.55%-253.99M | 11.54%-224.61M | -28.42%-185.58M | -4.44%-72.28M | -17.69%-332.22M | -88.82%-253.92M | -39.15%-144.51M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --930.12M | --930.12M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | -52.64%955.84M | -33.80%845.84M | -42.66%318.15M | 34.44%2.28B | 35.21%2.02B | 11.76%1.28B | 6.75%554.85M | 50.17%1.69B | 84.88%1.49B | 80.76%1.14B |
| Cash received relating to other financing activities | -11.41%647.56M | 6.75%428.05M | 14.43%230M | 53.10%572.17M | 193.57%731M | 301.00%401M | --201M | 131.44%373.72M | 211.25%249M | --100M |
| Cash inflows from financing activities | -7.85%2.53B | 31.30%2.2B | -27.48%548.15M | 37.81%2.85B | 57.85%2.75B | 35.03%1.68B | 45.42%755.85M | 59.92%2.07B | 95.52%1.74B | 96.58%1.24B |
| Borrowing repayment | -20.34%1.46B | -30.76%978.04M | -59.35%209.73M | 111.95%2.43B | 110.59%1.84B | 124.11%1.41B | 70.54%515.88M | -10.65%1.15B | -6.22%872.37M | -22.36%630.27M |
| Dividend interest payment | -35.42%95.25M | -57.98%52.45M | -19.22%23.79M | -10.09%195.65M | -23.29%147.51M | -23.86%124.81M | 65.87%29.45M | 8.26%217.6M | 4.68%192.28M | 2.10%163.91M |
| Cash payments relating to other financing activities | 29.20%631.45M | 320.00%420M | --300M | -58.48%141.42M | 44.20%488.74M | -60.95%100M | ---- | 207.40%340.61M | 19,879.82%338.92M | --256.1M |
| Cash outflows from financing activities | -11.45%2.19B | -11.41%1.45B | -2.17%533.52M | 62.33%2.77B | 76.22%2.47B | 55.89%1.64B | 70.28%545.33M | 6.88%1.71B | 25.81%1.4B | 8.02%1.05B |
| Net cash flows from financing activities | 24.43%343.36M | 1,723.95%753.52M | -93.05%14.63M | -77.17%83.01M | -18.40%275.94M | -78.58%41.31M | 5.51%210.52M | 220.48%363.58M | 250.39%338.15M | 156.74%192.86M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -168.67%-2.81M | -128.03%-1.24M | 56.13%-931.09K | -92.92%815.38K | -41.66%4.09M | 25.05%4.43M | -171.72%-2.12M | 4,767.44%11.51M | 373.35%7.01M | 253.99%3.54M |
| Net increase in cash and cash equivalents | -67.29%34.98M | 435.44%616.31M | -90.21%9.21M | -253.83%-125.61M | 322.20%106.94M | -39.50%-183.73M | 137.43%94.04M | 52.66%-35.5M | 63.25%-48.13M | 55.07%-131.71M |
| Add:Begin period cash and cash equivalents | -21.70%453.16M | -21.70%453.16M | -21.70%453.16M | -5.78%578.76M | -5.78%578.76M | -5.78%578.76M | -5.78%578.76M | -10.88%614.26M | -10.88%614.26M | -10.88%614.26M |
| End period cash equivalent | -28.81%488.14M | 170.73%1.07B | -31.28%462.37M | -21.70%453.16M | 21.12%685.7M | -18.14%395.03M | 2.90%672.8M | -5.78%578.76M | 1.40%566.14M | 21.83%482.55M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
